# Zenas BioPharma, Inc. (ZBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ZBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -80.99M | $ -75.20M | $ 351.73M | $ 335.83M |
| 2025 | $ 10.24M | $ -386.77M | $ -176.47M | $ 79.96M | $ 242.14M |
| 2024 | $ 5.26M | $ -165.01M | $ -125.92M | $ 1.00M | $ 312.46M |
| 2023 | $ 54.06M | $ -40.14M | $ -33.03M | $ 21.11M | $ -225.72M |
| 2022 | $ 0 | $ -21.22M | $ -20.33M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.05 |
| Liabilities / Eq | 1.23 |
| Current Ratio | 11.94 |

## Other views

- [Metrics](https://sponda.capital/en/ZBIO.md)
- [Charts](https://sponda.capital/en/ZBIO/charts.md)
- [Compare](https://sponda.capital/en/ZBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.